FGFR Inhibitors: Clinical Activity and Development in the Treatment of Cholangiocarcinoma
FGFR Inhibitors: Clinical Activity and Development in the Treatment of Cholangiocarcinoma
About this item
Full title
Author / Creator
Publisher
New York: Springer US
Journal title
Language
English
Formats
Publication information
Publisher
New York: Springer US
Subjects
More information
Scope and Contents
Contents
Purpose of Review
Cholangiocarcinoma is an aggressive cancer with a poor prognosis and limited treatment. Gene sequencing studies have identified genetic alterations in fibroblast growth factor receptor (
FGFR
) in a significant proportion of cholangiocarcinoma (CCA) patients. This review will discuss the
FGFR
signaling pathway’s rol...
Alternative Titles
Full title
FGFR Inhibitors: Clinical Activity and Development in the Treatment of Cholangiocarcinoma
Authors, Artists and Contributors
Author / Creator
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_proquest_miscellaneous_2552993400
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_2552993400
Other Identifiers
ISSN
1523-3790
E-ISSN
1534-6269
DOI
10.1007/s11912-021-01100-3
